Prognostic impacts of tumoral expression and serum levels of PD-L1 and CTLA-4 in colorectal cancer patients

被引：0
|
作者：
Yusuke Omura
Yuji Toiyama
Yoshinaga Okugawa
Chengzeng Yin
Tsunehiko Shigemori
Kurando Kusunoki
Yukina Kusunoki
Shozo Ide
Tadanobu Shimura
Hiroyuki Fujikawa
Hiromi Yasuda
Junichiro Hiro
Masaki Ohi
Masato Kusunoki
机构：
[1] Mie University Graduate School of Medicine,Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences
[2] Mie University Hospital,Department of Genomic Medicine
来源：
Cancer Immunology, Immunotherapy | 2020年 / 69卷
关键词：
Tumoral membrane expression; Soluble receptors and ligands; PD-L1; CTLA-4; Colorectal Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2533 / 2546
页数：13
相关论文
共 50 条
  • [41] Prognostic importance of PD-L1 expression in bladder cancer patients
    Durur, Sumeyye
    Uzun, Hakki
    Bedir, Recep
    Nalkiran, Ihsan
    Nalkiran, Hatice Sevim
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 : S633 - S638
  • [42] Prognostic importance of PD-L1 expression in bladder cancer patients
    Durur, Sumeyye
    Uzun, Hakki
    Bedir, Recep
    Nalkiran, Ihsan
    Nalkiran, Hatice Sevim
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (SUPPL 2) : S633 - S638
  • [43] Impact of Treatment on IL-10, CTLA-4 and PD-L1 Gene Expression in Patients with Classical Hodgkin Lymphoma
    Silva, Priscilla Brito
    Real, Juliana Monte
    Ferreira, Ludmila Rodrigues Pinto
    Esteves, Gustavo Henrique
    Garibaldi Junior, Joao
    Penna, Adriana M. Damasco
    Brito, Fabio Nascimento
    Cavalcante, Egyla
    Baiocchi, Otavio C. G.
    BLOOD, 2016, 128 (22)
  • [44] Neuro-Ophthalmic Complications in Patients Treated With CTLA-4 and PD-1/PD-L1 Checkpoint Blockade
    Sun, Michel M.
    Seleme, Nicolas
    Chen, John J.
    Zekeridou, Anastasia
    Sechi, Elia
    Walsh, Ryan D.
    Beebe, Johanna D.
    Sabbagh, Osama
    Mejico, Luis J.
    Gratton, Sean
    Skidd, Philip M.
    Bellows, David A.
    Falardeau, Julie
    Fraser, Clare L.
    Cappelen-Smith, Cecilia
    Haines, Scott R.
    Hassanzadeh, Bahareh
    Seay, Meagan D.
    Subramanian, Prem S.
    Williams, Zoe
    Gordon, Lynn K.
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2021, 41 (04) : 519 - 530
  • [45] PROGNOSTIC VALUE OF EXPRESSION OF PD-1 AND CTLA-4 IN PERIPHERAL BLOOD IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Eun, Hyuk Soo
    Lee, Tae Hee
    Lee, Jeongdong
    Kim, Min Seok
    Rou, Woo Sun
    Jeon, Hong Jae
    Kim, Seok Hyun
    Lee, Byung Seok
    Choi, Hei-Gwon
    Kim, Ha Neul
    Jang, Tae Min
    Lee, Ji Ah
    Son, Chae Yeon
    Bu, Jiyoon
    HEPATOLOGY, 2023, 78 : S1879 - S1880
  • [46] Targeting CTLA-4, PD-L1 and IDO to modulate immune responses in vitiligo
    Speeckaert, Reinhart
    van Geel, Nanja
    EXPERIMENTAL DERMATOLOGY, 2017, 26 (07) : 630 - 634
  • [47] Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups
    Lawrence P. Andrews
    Hiroshi Yano
    Dario A. A. Vignali
    Nature Immunology, 2019, 20 : 1425 - 1434
  • [48] Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups
    Andrews, Lawrence P.
    Yano, Hiroshi
    Vignali, Dario A. A.
    NATURE IMMUNOLOGY, 2019, 20 (11) : 1425 - 1434
  • [49] CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma
    Guo, Xiao-Jun
    Lu, Jia-Cheng
    Zeng, Hai-Ying
    Zhou, Rong
    Sun, Qi-Man
    Yang, Guo-Huan
    Pei, Yan-Zi
    Meng, Xian-Long
    Shen, Ying-Hao
    Zhang, Peng-Fei
    Cai, Jia-Bin
    Huang, Pei-Xin
    Ke, Ai-Wu
    Shi, Ying-Hong
    Zhou, Jian
    Fan, Jia
    Chen, Yi
    Yang, Liu-Xiao
    Shi, Guo-Ming
    Huang, Xiao-Yong
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [50] Expression and prognostic value of PD-1 and PD-L1 in colorectal carcinoma
    Aouadi, R.
    Helal, I.
    Khanchel, F.
    Hedhli, R.
    Ben Brahim, E.
    Jouini, R.
    Debbiche, A. Chadli
    VIRCHOWS ARCHIV, 2024, 485 : S151 - S152
12345